Selected research
Industry Research
Molecular Cloning Solutions Industry Research Report 2026
Market perspective
The global Molecular Cloning Solutions market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Molecular Cloning Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Molecular Cloning Solutions market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Molecular Cloning Solutions market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Molecular Cloning Solutions include VectorBuilder, BioServUK, GenScript, urofins Genomics, Innoprot, Genewiz, Bio-Fab Research, OriGene and Prospec-Tany Technogene, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Molecular Cloning Solutions market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Molecular Cloning Solutions.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Molecular Cloning Solutions Market by Company
VectorBuilder
BioServUK
GenScript
urofins Genomics
Innoprot
Genewiz
Bio-Fab Research
OriGene
Prospec-Tany Technogene
Addgene
Protein Ark
Protomnis
RD-Biotech
Charles River
Molecular Cloning Solutions Segment by Type
Restriction Enzyme Cloning
Primer Amplification Cloning
Gene Library Cloning
Gene Mutation Cloning
Genomic Cloning
Molecular Cloning Solutions Segment by Application
Laboratory
Research Institute
Others
Molecular Cloning Solutions Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Cloning Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Molecular Cloning Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Cloning Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Molecular Cloning Solutions companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Restriction Enzyme Cloning
- Primer Amplification Cloning
- Gene Library Cloning
- Gene Mutation Cloning
- Genomic Cloning
Applications
- Laboratory
- Research Institute
- Others
Companies covered
- VectorBuilder
- BioServUK
- GenScript
- urofins Genomics
- Innoprot
- Genewiz
- Bio-Fab Research
- OriGene
- Prospec-Tany Technogene
- Addgene
- Protein Ark
- Protomnis
- RD-Biotech
- Charles River
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Molecular Cloning Solutions by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Restriction Enzyme Cloning
- 2.2.3 Primer Amplification Cloning
- 2.2.4 Gene Library Cloning
- 2.2.5 Gene Mutation Cloning
- 2.2.6 Genomic Cloning
- 2.3 Molecular Cloning Solutions by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Laboratory
- 2.3.3 Research Institute
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Molecular Cloning Solutions Breakdown Data by Type
- 3.1 Global Molecular Cloning Solutions Historic Market Size by Type (2021-2026)
- 3.2 Global Molecular Cloning Solutions Forecasted Market Size by Type (2027-2032)
4 Molecular Cloning Solutions Breakdown Data by Application
- 4.1 Global Molecular Cloning Solutions Historic Market Size by Application (2021-2026)
- 4.2 Global Molecular Cloning Solutions Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Molecular Cloning Solutions Market Perspective (2021-2032)
- 5.2 Global Molecular Cloning Solutions Growth Trends by Region
- 5.2.1 Global Molecular Cloning Solutions Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Molecular Cloning Solutions Historic Market Size by Region (2021-2026)
- 5.2.3 Molecular Cloning Solutions Forecasted Market Size by Region (2027-2032)
- 5.3 Molecular Cloning Solutions Market Dynamics
- 5.3.1 Molecular Cloning Solutions Industry Trends
- 5.3.2 Molecular Cloning Solutions Market Drivers
- 5.3.3 Molecular Cloning Solutions Market Challenges
- 5.3.4 Molecular Cloning Solutions Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Molecular Cloning Solutions Players by Revenue
- 6.1.1 Global Top Molecular Cloning Solutions Players by Revenue (2021-2026)
- 6.1.2 Global Molecular Cloning Solutions Revenue Market Share by Players (2021-2026)
- 6.2 Global Molecular Cloning Solutions Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Molecular Cloning Solutions Head Office and Area Served
- 6.4 Global Molecular Cloning Solutions Players, Product Type & Application
- 6.5 Global Molecular Cloning Solutions Manufacturers Established Date
- 6.6 Global Molecular Cloning Solutions Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Molecular Cloning Solutions Market Size (2021-2032)
- 7.2 North America Molecular Cloning Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Molecular Cloning Solutions Market Size by Country (2021-2026)
- 7.4 North America Molecular Cloning Solutions Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Molecular Cloning Solutions Market Size (2021-2032)
- 8.2 Europe Molecular Cloning Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Molecular Cloning Solutions Market Size by Country (2021-2026)
- 8.4 Europe Molecular Cloning Solutions Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Molecular Cloning Solutions Market Size (2021-2032)
- 9.2 Asia-Pacific Molecular Cloning Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Molecular Cloning Solutions Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Molecular Cloning Solutions Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Molecular Cloning Solutions Market Size (2021-2032)
- 10.2 South America Molecular Cloning Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Molecular Cloning Solutions Market Size by Country (2021-2026)
- 10.4 South America Molecular Cloning Solutions Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Molecular Cloning Solutions Market Size (2021-2032)
- 11.2 Middle East & Africa Molecular Cloning Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Molecular Cloning Solutions Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Molecular Cloning Solutions Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 VectorBuilder
- 12.1.1 VectorBuilder Company Information
- 12.1.2 VectorBuilder Business Overview
- 12.1.3 VectorBuilder Revenue in Molecular Cloning Solutions Business (2021-2026)
- 12.1.4 VectorBuilder Molecular Cloning Solutions Product Portfolio
- 12.1.5 VectorBuilder Recent Developments
- 12.2 BioServUK
- 12.2.1 BioServUK Company Information
- 12.2.2 BioServUK Business Overview
- 12.2.3 BioServUK Revenue in Molecular Cloning Solutions Business (2021-2026)
- 12.2.4 BioServUK Molecular Cloning Solutions Product Portfolio
- 12.2.5 BioServUK Recent Developments
- 12.3 GenScript
- 12.3.1 GenScript Company Information
- 12.3.2 GenScript Business Overview
- 12.3.3 GenScript Revenue in Molecular Cloning Solutions Business (2021-2026)
- 12.3.4 GenScript Molecular Cloning Solutions Product Portfolio
- 12.3.5 GenScript Recent Developments
- 12.4 urofins Genomics
- 12.4.1 urofins Genomics Company Information
- 12.4.2 urofins Genomics Business Overview
- 12.4.3 urofins Genomics Revenue in Molecular Cloning Solutions Business (2021-2026)
- 12.4.4 urofins Genomics Molecular Cloning Solutions Product Portfolio
- 12.4.5 urofins Genomics Recent Developments
- 12.5 Innoprot
- 12.5.1 Innoprot Company Information
- 12.5.2 Innoprot Business Overview
- 12.5.3 Innoprot Revenue in Molecular Cloning Solutions Business (2021-2026)
- 12.5.4 Innoprot Molecular Cloning Solutions Product Portfolio
- 12.5.5 Innoprot Recent Developments
- 12.6 Genewiz
- 12.6.1 Genewiz Company Information
- 12.6.2 Genewiz Business Overview
- 12.6.3 Genewiz Revenue in Molecular Cloning Solutions Business (2021-2026)
- 12.6.4 Genewiz Molecular Cloning Solutions Product Portfolio
- 12.6.5 Genewiz Recent Developments
- 12.7 Bio-Fab Research
- 12.7.1 Bio-Fab Research Company Information
- 12.7.2 Bio-Fab Research Business Overview
- 12.7.3 Bio-Fab Research Revenue in Molecular Cloning Solutions Business (2021-2026)
- 12.7.4 Bio-Fab Research Molecular Cloning Solutions Product Portfolio
- 12.7.5 Bio-Fab Research Recent Developments
- 12.8 OriGene
- 12.8.1 OriGene Company Information
- 12.8.2 OriGene Business Overview
- 12.8.3 OriGene Revenue in Molecular Cloning Solutions Business (2021-2026)
- 12.8.4 OriGene Molecular Cloning Solutions Product Portfolio
- 12.8.5 OriGene Recent Developments
- 12.9 Prospec-Tany Technogene
- 12.9.1 Prospec-Tany Technogene Company Information
- 12.9.2 Prospec-Tany Technogene Business Overview
- 12.9.3 Prospec-Tany Technogene Revenue in Molecular Cloning Solutions Business (2021-2026)
- 12.9.4 Prospec-Tany Technogene Molecular Cloning Solutions Product Portfolio
- 12.9.5 Prospec-Tany Technogene Recent Developments
- 12.10 Addgene
- 12.10.1 Addgene Company Information
- 12.10.2 Addgene Business Overview
- 12.10.3 Addgene Revenue in Molecular Cloning Solutions Business (2021-2026)
- 12.10.4 Addgene Molecular Cloning Solutions Product Portfolio
- 12.10.5 Addgene Recent Developments
- 12.11 Protein Ark
- 12.11.1 Protein Ark Company Information
- 12.11.2 Protein Ark Business Overview
- 12.11.3 Protein Ark Revenue in Molecular Cloning Solutions Business (2021-2026)
- 12.11.4 Protein Ark Molecular Cloning Solutions Product Portfolio
- 12.11.5 Protein Ark Recent Developments
- 12.12 Protomnis
- 12.12.1 Protomnis Company Information
- 12.12.2 Protomnis Business Overview
- 12.12.3 Protomnis Revenue in Molecular Cloning Solutions Business (2021-2026)
- 12.12.4 Protomnis Molecular Cloning Solutions Product Portfolio
- 12.12.5 Protomnis Recent Developments
- 12.13 RD-Biotech
- 12.13.1 RD-Biotech Company Information
- 12.13.2 RD-Biotech Business Overview
- 12.13.3 RD-Biotech Revenue in Molecular Cloning Solutions Business (2021-2026)
- 12.13.4 RD-Biotech Molecular Cloning Solutions Product Portfolio
- 12.13.5 RD-Biotech Recent Developments
- 12.14 Charles River
- 12.14.1 Charles River Company Information
- 12.14.2 Charles River Business Overview
- 12.14.3 Charles River Revenue in Molecular Cloning Solutions Business (2021-2026)
- 12.14.4 Charles River Molecular Cloning Solutions Product Portfolio
- 12.14.5 Charles River Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst